,mean_rank,weight
cervix,16.0,3.0
lung carcinoma,19.0,1.0
adrenal gland,26.0,3.0
small cell lung carcinoma,31.5,88.0
supraclavicular lymph node,34.0,3.0
pancreatic somatostatinoma,35.0,3.0
lung carcinoid tumor,57.0,6.0
thyroid gland squamous cell carcinoma,58.0,3.0
medulloblastoma,62.0,8.0
adrenal gland neuroblastoma,64.0,5.0
abdomen,76.0,2.0
endometrioid stromal sarcoma,76.0,3.0
neuroblastoma,76.5,52.0
rhabdomyosarcoma,78.5,4.0
right anterior leg,90.0,3.0
embryonal carcinoma,92.0,1.0
mediastinal lymph node,97.0,1.0
skin nodule,104.0,1.0
inguinal lymph node,119.0,3.0
biphasic synovial sarcoma,121.0,1.0
hereditary thyroid gland medullary carcinoma,122.0,1.0
multiple endocrine neoplasia type 2,122.0,1.0
prostate carcinoma,123.0,11.0
embryonal rhabdomyosarcoma,125.0,6.0
vertebra,128.5,2.0
ewing sarcoma,129.0,31.0
osteosarcoma,139.0,23.0
large cell lung carcinoma,140.0,32.0
squamous papilloma,142.0,1.0
liposarcoma,142.0,1.0
high grade ovarian serous adenocarcinoma,143.0,40.0
right thigh skin,145.0,2.0
papillary renal cell carcinoma,147.0,5.0
gastric adenosquamous carcinoma,159.5,2.0
brain,160.5,16.0
thoracic lymph duct,163.0,1.0
pharyngeal squamous cell carcinoma,165.0,3.0
"squamous cell breast carcinoma, acantholytic variant",166.0,3.0
ovarian serous adenocarcinoma,167.0,7.0
pleural sarcomatoid mesothelioma,167.5,8.0
duodenal adenocarcinoma,172.0,1.0
right pararenal lymph node,180.0,2.0
ovarian carcinoma,181.0,6.0
uterine carcinosarcoma,182.5,2.0
ovarian leiomyosarcoma,184.0,3.0
gastric small cell neuroendocrine carcinoma,187.0,4.0
brca1 syndrome,193.0,1.0
myeloid leukemia associated with down syndrome,195.0,1.0
lung mucoepidermoid carcinoma,196.0,3.0
salivary gland squamous cell carcinoma,204.0,3.0
alveolar rhabdomyosarcoma,206.0,9.0
subserosa of fallopian tube,208.0,1.0
thyroid gland follicular carcinoma,209.5,10.0
bone marrow,212.0,65.0
vaginal melanoma,214.0,1.0
cervical squamous cell carcinoma,218.0,1.0
bronchogenic carcinoma,220.0,2.0
ovarian endometrioid adenocarcinoma,231.0,11.0
peritoneal ascites,234.5,2.0
oligodendroglioma,235.0,5.0
lung giant cell carcinoma,236.0,4.0
cutaneous melanoma,236.5,26.0
brca2 syndrome,245.0,1.0
oral cavity squamous cell carcinoma,246.5,6.0
adenosquamous lung carcinoma,257.0,9.0
squamous cell lung carcinoma,258.5,48.0
subcutaneous,262.0,7.0
bladder squamous cell carcinoma,264.0,3.0
cervical small cell carcinoma,265.0,1.0
axillary lymph node,265.5,6.0
small intestine,266.0,1.0
not specified,270.0,3.0
vulvar leiomyosarcoma,277.0,3.0
esophageal squamous cell carcinoma,278.0,59.0
endometrial adenosquamous carcinoma,279.0,6.0
poorly differentiated thyroid gland carcinoma,279.0,3.0
tonsillar squamous cell carcinoma,285.0,1.0
minimally invasive lung adenocarcinoma,287.0,16.0
ovarian granulosa cell tumor,288.5,2.0
testicular embryonal carcinoma,291.0,1.0
ovarian serous cystadenocarcinoma,291.0,4.0
endometrial carcinoma,294.5,8.0
primitive neuroectodermal tumor,295.0,2.0
right axillary lymph node,302.0,1.0
neurofibromatosis type 1,303.0,1.0
melanoma,305.0,94.0
glioblastoma,306.0,84.0
abdominal wall,308.5,2.0
plasma cell myeloma,310.5,30.0
hodgkin lymphoma,311.0,11.0
ductal breast carcinoma,319.0,32.0
chondrosarcoma,320.5,10.0
pleural epithelioid mesothelioma,321.5,18.0
skin,323.0,3.0
lymph node,325.0,105.0
gastric fundus carcinoma,326.0,1.0
astrocytoma,327.0,19.0
pleural biphasic mesothelioma,327.0,7.0
hypopharyngeal squamous cell carcinoma,330.0,5.0
bladder carcinoma,332.0,51.0
thyroid gland undifferentiated (anaplastic) carcinoma,339.0,13.0
erythroleukemia,341.0,3.0
laryngeal squamous cell carcinoma,341.5,12.0
amelanotic melanoma,342.0,16.0
renal cell carcinoma,345.0,37.0
pleural effusion,349.0,224.0
breast carcinoma,349.0,27.0
pelvic wall,352.0,3.0
spleen,356.0,3.0
ovarian clear cell adenocarcinoma,356.0,13.0
ascites,361.0,103.0
celiac axis lymph node,363.5,2.0
groin lymph node,375.0,5.0
clear cell renal cell carcinoma,379.0,18.0
lung adenocarcinoma,381.0,145.0
human papillomavirus-related endocervical adenocarcinoma,383.5,4.0
left leg muscle,386.0,3.0
cystic fibrosis,390.5,2.0
n/a,390.5,34.0
burkitt lymphoma,392.0,8.0
intrahepatic cholangiocarcinoma,393.0,6.0
acute myeloid leukemia,398.0,1.0
mucinous gastric adenocarcinoma,401.0,3.0
intraperitoneal,401.0,1.0
marek disease,406.0,1.0
pancreatic adenocarcinoma,407.0,39.0
oral dysplasia,408.0,1.0
fibrosarcoma,411.0,5.0
pancreatic carcinoma,413.0,12.0
gliosarcoma,414.5,6.0
myelodysplastic syndrome,416.0,1.0
diffuse large b-cell lymphoma activated b-cell type,417.0,1.0
supra-orbital region,421.0,1.0
thyroid gland sarcoma,425.0,1.0
pancreatic adenosquamous carcinoma,426.0,5.0
pleural malignant mesothelioma,428.0,5.0
endometrial adenocarcinoma,431.0,34.0
hepatocellular carcinoma,431.0,51.0
benign prostatic hyperplasia,432.0,1.0
liver,433.0,32.0
tongue squamous cell carcinoma,433.5,34.0
"invasive ductal carcinoma, not otherwise specified",435.0,30.0
gallbladder carcinoma,437.0,2.0
invasive lobular breast carcinoma,440.0,1.0
gastric tubular adenocarcinoma,441.0,11.0
anaplastic large cell lymphoma,443.5,8.0
ovarian adenocarcinoma,444.0,5.0
ovarian mucinous adenocarcinoma,444.5,4.0
cerebrospinal fluid,445.0,3.0
pancreatic ductal adenocarcinoma,454.0,39.0
lung,460.0,7.0
childhood t lymphoblastic lymphoma,463.0,2.0
gastric carcinoma,464.5,12.0
non-small cell lung carcinoma,464.5,24.0
colon adenocarcinoma,465.0,61.0
ampulla of vater adenocarcinoma,466.0,2.0
gastric adenocarcinoma,467.5,26.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",468.0,2.0
undifferentiated gallbladder carcinoma,468.0,1.0
"chronic myelogenous leukemia, bcr-abl1 positive",470.5,16.0
undifferentiated pleomorphic sarcoma,471.5,4.0
gingival squamous cell carcinoma,472.5,2.0
hairy cell leukemia,474.0,3.0
malignant ovarian brenner tumor,475.0,1.0
cervical carcinoma,476.5,2.0
cervical lymph node,480.0,5.0
uterine corpus leiomyosarcoma,481.0,3.0
omentum,487.0,7.0
ovarian mucinous cystadenocarcinoma,488.0,2.0
cecum adenocarcinoma,488.5,18.0
adult acute monocytic leukemia,489.0,5.0
peritoneum,491.0,1.0
colon carcinoma,492.0,19.0
down syndrome,494.5,2.0
ovarian cystadenocarcinoma,495.5,6.0
breast adenocarcinoma,497.0,23.0
buttock,497.0,2.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),498.0,4.0
epithelioid cell type gastrointestinal stromal tumor,498.0,3.0
mantle cell lymphoma,499.0,6.0
natural killer cell lymphoblastic leukemia/lymphoma,503.0,1.0
rhabdoid tumor of the kidney,505.0,3.0
recurrent bladder carcinoma,509.0,3.0
pericardial effusion,510.0,8.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",511.5,2.0
skin squamous cell carcinoma,512.0,1.0
brachialis muscle,513.0,3.0
askin tumor,515.5,2.0
peripheral blood,516.0,107.0
anaplastic astrocytoma,517.0,5.0
left supraclavicular lymph node,522.5,4.0
familial adenomatous polyposis,523.0,1.0
hepatoblastoma,525.0,4.0
chronic lymphocytic leukemia,533.5,2.0
epstein-barr virus-related burkitt lymphoma,536.0,10.0
rectal adenocarcinoma,543.0,11.0
rectosigmoid adenocarcinoma,551.0,3.0
childhood t acute lymphoblastic leukemia,557.0,19.0
uterine corpus sarcoma,557.0,3.0
obturator lymph node,560.0,3.0
hilar cholangiocarcinoma,563.0,1.0
esophageal adenocarcinoma,568.0,9.0
barrett adenocarcinoma,568.0,3.0
signet ring cell gastric adenocarcinoma,569.0,9.0
childhood acute myeloid leukemia,579.0,2.0
buccal mucosa squamous cell carcinoma,591.0,2.0
paragastric lymph node,593.0,2.0
lymphoblastic lymphoma,594.0,1.0
diffuse large b-cell lymphoma germinal center b-cell type,606.5,8.0
thigh skin,615.0,1.0
mycosis fungoides and sezary syndrome,619.5,2.0
ovarian mixed germ cell tumor,620.0,1.0
mandible,624.0,1.0
subcutaneous; right buttock,626.0,3.0
peritoneal effusion,632.5,6.0
papillary lung adenocarcinoma,633.0,3.0
adult t acute lymphoblastic leukemia,634.0,5.0
cholangiocarcinoma,637.0,2.0
pelvis; innominate bone,659.0,2.0
b-cell prolymphocytic leukemia,662.5,2.0
adrenal cortex carcinoma,663.0,1.0
hereditary spherocytosis,665.0,1.0
b acute lymphoblastic leukemia,668.0,5.0
diffuse large b-cell lymphoma,668.0,20.0
adult acute myeloid leukemia,668.5,22.0
cutaneous t-cell non-hodgkin lymphoma,670.0,2.0
human papillomavirus-related cervical squamous cell carcinoma,670.5,8.0
head and neck squamous cell carcinoma,671.0,9.0
bone,679.0,1.0
adult b acute lymphoblastic leukemia,697.0,3.0
gestational choriocarcinoma,702.5,2.0
b-cell non-hodgkin lymphoma,716.0,7.0
lymphoma,732.0,1.0
splenic lymphoma with circulating villous lymphocytes,736.0,1.0
floor of mouth squamous cell carcinoma,744.0,1.0
pyriform fossa squamous cell carcinoma,748.0,1.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,785.0,3.0
childhood b acute lymphoblastic leukemia,785.0,9.0
primary effusion lymphoma,801.0,3.0
gastric choriocarcinoma,802.0,1.0
thyroid gland papillary carcinoma,806.0,1.0
left cervical lymph node,806.0,1.0
vulvar carcinoma,809.0,1.0
vulvar squamous cell carcinoma,813.0,3.0
childhood acute monocytic leukemia,835.5,2.0
meninges,838.0,1.0
acute myelomonocytic leukemia,838.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,886.0,1.0
squamous cell carcinoma,892.0,1.0
ovary,912.0,1.0
"chronic eosinophilic leukemia, not otherwise specified",932.0,1.0
childhood acute myeloid leukemia with maturation,933.0,1.0
vulvar melanoma,934.0,1.0
mediastinal (thymic) large b-cell lymphoma,939.0,1.0
follicular lymphoma,940.0,2.0
epithelioid sarcoma,954.0,1.0
parotid gland mucoepidermoid carcinoma,955.0,1.0
